Skip to main content
. 2017 Feb 22;153(5):436–441. doi: 10.1001/jamadermatol.2016.6138

Table 1. Patient and Tumor Characteristics.

Variable MMS
(n = 277)
WLE
(n = 385)
P Value
Age, mean (SD), y 64.0 (13.1) 58.5 (15.6) <.001
Sex, No. (%)
Male 172 (62.1) 211 (54.8) .06
Female 105 (37.9) 174 (45.2)
Race, No. (%)
White 252 (91.0) 354 (91.9) .66
Other/unknown 25 (9.0) 31 (8.1)
Year of diagnosis
Mean (SD) 2007 (3.9) 2003 (5.6) <.001
Median (range) 2008 (1986-2013) 2003 (1978-2013)
Tumor diameter,a cm
Mean (SD) 1.8 (1.5) 1.6 (1.1) .21
Median (IQR) 1.4 (0.5-9.0) 1.3 (0.1-8.3)
Anatomic site, No. (%)b
Face 222 (80.2) 141 (36.7) <.001
Scalp/neck 23 (8.3) 26 (6.8)
Trunk 10 (3.6) 73 (19.0)
Upper extremity 13 (4.7) 85 (22.1)
Lower extremity 9 (3.2) 59 (15.4)
WLE surgical margins, mean (SD), cm NA 0.6 (0.3)
Recurrences, No. (%) 5 (1.8) 22 (5.7) .07
WLE margin taken, mean (SD), cm
Recurred NA 0.9 (0.2) .003
Not recurred NA 0.6 (0.04)
Time to recurrence, mean (SD), y 3.91 (4.4) 4.45 (2.7) .73
Deaths, No. (%)c
All cause 37 (13.4) 75 (19.5)
Melanoma specific 2 (0.7) 13 (3.4)
Time to death, mean (SD), y
All cause 18.4 (0.8) 17.4 (0.4) .28
Melanoma specific 6.5 (4.8) 6.1 (0.8) .77

Abbreviations: IQR, interquartile range; MMS, Mohs micrographic surgery; NA, not applicable; WLE, wide local excision.

a

Preoperative assessment of 107 MMS-treated patients and 74 WLE-treated patients.

b

Assessment of 277 MMS-treated patients and 384 WLE-treated patients.

c

P values not given because a statistical test comparing the raw counts/percentages does not account for differential follow-up time (see time to death analyses).